Important Context While the preclinical data is extensive and promising, it is essential to note that BPC-157 has not been evaluated in large-scale, randomized controlled human trials
The experts reviewed the efficacy, safety, and clinical implications of REDEFINE 1 and REDEFINE 2, contributing to the evolving understanding of how amylin and GLP-1s interact in regulating metabolism and offering a new strategy for treating obesity and T2D
Still, physicians are wary of lack of inclusion of GLP-1RA drugs in clinical guidelines yet are optimistic that more research and evidence will be forthcoming
Patent and Trademark Office at any time during a drug's development
The label also advises not to take these capsules within six hours of going to sleep, and not to exceed four capsules in a 24-hour period
A Complete Response Letter (CRL) from the FDA, essentially a request for more information or additional studies, would add at least 12 months to the timeline